← Open Payments lookup

BECKY BOLE: Open Payments

NPI 1043621576 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$487 in 22 payments from 12 companies in 2025. Trend: 2023 $1,836 · 2024 $1,000 · 2025 $487

Food & beverage: $487
CompanyPaymentsAmount
Antares Pharma, Inc.4$96
Otsuka America Pharmaceutical, Inc.5$90
E.R. Squibb & Sons, L.L.C.1$77
Alkermes, Inc.3$64
Novo Nordisk Inc1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Corium, LLC2$21
Xeris Pharmaceuticals, Inc.1$20
Lilly USA, LLC1$20
Corcept Therapeutics1$19

Products named: XYOSTED, COBENFY, REXULTI, LYBALVI, ABILIFY ASIMTUFII, ARISTADA, Wegovy, CAPLYTA.

Industry payments across ID — which companies pay providers there.